Arlington, MA, United States of America

Mark N Lee

This inventor holds 1 USPTO granted patent. Top assignee: Dana-Farber-Cancer Institute Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mark N Lee. Retrieved from https://idiyas.com/inventor/mark-n-lee

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mark N Lee: Innovator in T Cell Epitope Identification

Introduction

Mark N Lee is a notable inventor based in Arlington, MA (US). He has made significant contributions to the field of immunology, particularly in the identification of T cell epitopes. His work is crucial for advancing cancer research and treatment.

Latest Patents

Mark N Lee holds a patent titled "Methods of High-Throughput Identification of T Cell Epitopes by Capturing Cytokines on the Surface of Antigen-Presenting Cells." This innovative method enhances the efficiency of identifying T cell epitopes, which is vital for developing targeted therapies.

Career Highlights

Mark is currently affiliated with the Dana-Farber Cancer Institute Inc., where he continues to push the boundaries of cancer research. His dedication to improving patient outcomes through innovative research is commendable.

Collaborations

One of his notable collaborators is Matthew Meyerson, with whom he has worked on various projects aimed at enhancing cancer treatment methodologies.

Conclusion

Mark N Lee's contributions to the field of immunology and cancer research through his innovative patent and collaborations highlight his importance as an inventor. His work continues to pave the way for advancements in targeted cancer therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…